Glicpal M

Glicpal M combines Gliclazide (80 mg) and Metformin Hydrochloride (500 mg) to provide effective management of type 2 diabetes mellitus. Gliclazide is an oral hypoglycemic agent that stimulates insulin secretion from the pancreas, while Metformin enhances insulin sensitivity and reduces hepatic glucose production. Together, these medications work synergistically to improve glycemic control and lower blood sugar levels, helping patients achieve better diabetes management and reducing the risk of complications.